Search - tctmd.com

Displaying 541 - 560 of 592

Sort: Relevancy | Date

News Daily News

Una Puntuación de Calcio Igual a 0 Ofrece una ‘Ventaja’ sobre la Mortalidad de 15 Años de Duración en Pacientes Asintomáticos

August 06, 2015

News Daily News

钙化评分为零“保证”了无症状患者 15 年死亡率

August 06, 2015

News Daily News

Bivalirudina + GPI Reduce las Hemorragias y Mortalidad de Pacientes con ICC sometidos a PCI

June 09, 2015

News Daily News

比伐卢定加 GPI 可减少接受 PCI 的心衰患者的出血和死亡率

June 09, 2015

News Daily News

Bivalirudin Plus GPI Cuts Bleeding, Mortality in Heart Failure Patients Undergoing PCI

June 09, 2015

Presentation TCT 2014

TCT 475: Triple Antithrombotic Therapy Versus Dual Antiplatelet Therapy in Patients with Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation

Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, Dong Oh Kang

September 15, 2014

Presentation TCT 2014

TCT 474: Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndromes: The AVIATOR Registry

Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, Georgios Christodoulidis

September 15, 2014

Presentation TCT 2014

When Should Aspirin Be Dropped From Triple Therapy? Musings on Woest and Beyond

Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, Harvey D. White

September 15, 2014

Presentation TCT 2014

TCT 467: Bivalirudin vs Heparin for Percutaneous Coronary Intervention: An Updated Meta-analysis of Randomized Controlled Trials

Presenter: David J. Moliterno, E. Magnus Ohman, Duane S. Pinto, Michael Lipinski

September 14, 2014

Presentation TCT 2014

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

Presenter: Kishore J. Harjai, Michael S. Lee

September 14, 2014

News Daily News

El Cambio Intrahospitalario de Agentes Antiplaquetarios en Pacientes PCI es Relativamente Frecuente y está Condicionado por el Riesgo del Paciente y Otros Factores

L.A. McKeown

August 20, 2014

News Daily News

心肌梗塞患者院内抗血小板药切换比较常见，主要原因是患者风险及其他因素

L.A. McKeown

August 20, 2014

News Daily News

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

Todd Neale

August 20, 2014

News Daily News

In-Hospital Switching of Antiplatelet Agents in MI Patients Relatively Common, Driven by Patient Risk, Other Factors

L.A. McKeown

August 20, 2014

News Daily News

Hospital-Level Factors Likely Explain Why Some VA Patients Don’t Get Timely Post-PCI Clopidogrel

Caitlin E. Cox

June 17, 2014

News Daily News

Factores Hospitalarios Podrían Explicar Por Qué Algunos Pacientes Veteranos No Reciben Clopidogrel Post-PCI en el Momento Oportuno

Caitlin E. Cox

June 17, 2014

News Daily News

Apixaban es Rentable comparado con Warfarina o Aspirina

Caitlin E. Cox

February 26, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

Advertisement

Una Puntuación de Calcio Igual a 0 Ofrece una ‘Ventaja’ sobre la Mortalidad de 15 Años de Duración en Pacientes Asintomáticos

钙化评分为零“保证”了无症状患者 15 年死亡率

Bivalirudina + GPI Reduce las Hemorragias y Mortalidad de Pacientes con ICC sometidos a PCI

比伐卢定加 GPI 可减少接受 PCI 的心衰患者的出血和死亡率

Bivalirudin Plus GPI Cuts Bleeding, Mortality in Heart Failure Patients Undergoing PCI

TCT 475: Triple Antithrombotic Therapy Versus Dual Antiplatelet Therapy in Patients with Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation

TCT 474: Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndromes: The AVIATOR Registry

When Should Aspirin Be Dropped From Triple Therapy? Musings on Woest and Beyond

TCT 467: Bivalirudin vs Heparin for Percutaneous Coronary Intervention: An Updated Meta-analysis of Randomized Controlled Trials

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

El Cambio Intrahospitalario de Agentes Antiplaquetarios en Pacientes PCI es Relativamente Frecuente y está Condicionado por el Riesgo del Paciente y Otros Factores

心肌梗塞患者院内抗血小板药切换比较常见，主要原因是患者风险及其他因素

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

In-Hospital Switching of Antiplatelet Agents in MI Patients Relatively Common, Driven by Patient Risk, Other Factors

Hospital-Level Factors Likely Explain Why Some VA Patients Don’t Get Timely Post-PCI Clopidogrel

Factores Hospitalarios Podrían Explicar Por Qué Algunos Pacientes Veteranos No Reciben Clopidogrel Post-PCI en el Momento Oportuno

Apixaban es Rentable comparado con Warfarina o Aspirina

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content